Cathepsin G is differentially expressed in primary human antigen-presenting cells

Cellular Immunology

Volumn 255, Issue 1-2, 2009, Pages 41-45

  Stoeckle, Christina ^a   Sommandas, Vinod ^b,c   Adamopoulou, Eleni ^d   Belisle, Kurt ^f   Schiekofer, Stephan ^f   Melms, Arthur ^a   Weber, Ekkehard ^e   Driessen, Christoph ^b,c   Boehm, Bernhard O ^f   Tolosa, Eva ^a   Burster, Timo ^f  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Medical and Natural Sciences Research Centre   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^f UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

B cells; Cathepsin; Cathepsin G; Myeloid DC; Plasmacytoid DC

Indexed keywords

ASPARTIC PROTEINASE; CATHEPSIN G; CYSTEINE; MYELIN BASIC PROTEIN;

ANTIGEN PRESENTING CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LOCALIZATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; T LYMPHOCYTE;

EID: 59349120953     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2008.10.001     Document Type: Article

References (36)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Shortman K., and Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 7 (2007) 19-30
3. Lindstedt M., Lundberg K., and Borrebaeck C.A. Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J. Immunol. 175 (2005) 4839-4846
4. Zavasnik-Bergant T., and Turk B. Cysteine cathepsins in the immune response. Tissue Antigens 67 (2006) 349-355
5. Riese R.J., and Chapman H.A. Cathepsins and compartmentalization in antigen presentation. Curr. Opin. Immunol. 12 (2000) 107-113
6. Rudensky A., and Beers C. Lysosomal cysteine proteases and antigen presentation. Ernst Schering Res. Found Workshop (2006) 81-95
7. Watts C., Matthews S.P., Mazzeo D., Manoury B., and Moss C.X. Asparaginyl endopeptidase: case history of a class II MHC compartment protease. Immunol. Rev. 207 (2005) 218-228
8. Villadangos J.A., Riese R.J., Peters C., Chapman H.A., and Ploegh H.L. Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 186 (1997) 549-560
9. Shi G.P., Villadangos J.A., Dranoff G., Small C., Gu L., Haley K.J., Riese R., Ploegh H.L., and Chapman H.A. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10 (1999) 197-206
10. Nakagawa T.Y., Brissette W.H., Lira P.D., Griffiths R.J., Petrushova N., Stock J., McNeish J.D., Eastman S.E., Howard E.D., Clarke S.R., Rosloniec E.F., Elliott E.A., and Rudensky A.Y. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10 (1999) 207-217
11. Chapman H.A. Endosomal proteases in antigen presentation. Curr. Opin. Immunol. 18 (2006) 78-84
12. Tolosa E., Li W., Yasuda Y., Wienhold W., Denzin L.K., Lautwein A., Driessen C., Schnorrer P., Weber E., Stevanovic S., Kurek R., Melms A., and Bromme D. Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. J. Clin. Invest. 112 (2003) 517-526
13. Yasuda Y., Li Z., Greenbaum D., Bogyo M., Weber E., and Bromme D. Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages. J. Biol. Chem. 279 (2004) 36761-36770
14. Maehr R., Hang H.C., Mintern J.D., Kim Y.M., Cuvillier A., Nishimura M., Yamada K., Shirahama-Noda K., Hara-Nishimura I., and Ploegh H.L. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice. J. Immunol. 174 (2005) 7066-7074
15. Costantino C.M., Hang H.C., Kent S.C., Hafler D.A., and Ploegh H.L. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation. J. Immunol. 180 (2008) 2876-2885
16. Shi G.P., Bryant R.A., Riese R., Verhelst S., Driessen C., Li Z., Bromme D., Ploegh H.L., and Chapman H.A. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191 (2000) 1177-1186
17. Kos J., Sekirnik A., Premzl A., Zavasnik Bergant V., Langerholc T., Turk B., Werle B., Golouh R., Repnik U., Jeras M., and Turk V. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. Exp. Cell Res. 306 (2005) 103-113
18. Lennon-Dumenil A.M., Bakker A.H., Maehr R., Fiebiger E., Overkleeft H.S., Rosemblatt M., Ploegh H.L., and Lagaudriere-Gesbert C. Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 196 (2002) 529-540
19. Lautwein A., Kraus M., Reich M., Burster T., Brandenburg J., Overkleeft H.S., Schwarz G., Kammer W., Weber E., Kalbacher H., Nordheim A., and Driessen C. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner. J. Leukoc. Biol. 75 (2004) 844-855
20. Burster T., Beck A., Tolosa E., Schnorrer P., Weissert R., Reich M., Kraus M., Kalbacher H., Haring H.U., Weber E., Overkleeft H., and Driessen C. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells. J. Immunol. 175 (2005) 5940-5949
21. Chain B.M., Free P., Medd P., Swetman C., Tabor A.B., and Terrazzini N. The expression and function of cathepsin E in dendritic cells. J. Immunol. 174 (2005) 1791-1800
22. Moss C.X., Villadangos J.A., and Watts C. Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing. Eur. J. Immunol. 35 (2005) 3442-3451
23. Bennett K., Levine T., Ellis J.S., Peanasky R.J., Samloff I.M., Kay J., and Chain B.M. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin E. Eur. J. Immunol. 22 (1992) 1519-1524
24. Zaidi N., Burster T., Sommandas V., Herrmann T., Boehm B.O., Driessen C., Voelter W., and Kalbacher H. A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A. Biochem. Biophys. Res. Commun. 364 (2007) 243-249
25. Burster T., Beck A., Tolosa E., Marin-Esteban V., Rotzschke O., Falk K., Lautwein A., Reich M., Brandenburg J., Schwarz G., Wiendl H., Melms A., Lehmann R., Stevanovic S., Kalbacher H., and Driessen C. Cathepsin G, and not the asparagine-specific endoprotease controls the processing of myelin basic protein in lysosomes from human B lymphocytes. J. Immunol. 172 (2004) 5495-5503
26. Burster T., Beck A., Poeschel S., Oren A., Baechle D., Reich M., Roetzschke O., Falk K., Boehm B.O., Youssef S., Kalbacher H., Overkleeft H., Tolosa E., and Driessen C. Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro. Immunology 121 (2007) 82-93
27. Greenbaum D., Medzihradszky K.F., Burlingame A., and Bogyo M. Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools. Chem. Biol. 7 (2000) 569-581
28. Oleksyszyn J., and Powers J.C. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters. Biochemistry 30 (1991) 485-493
29. Bielekova B., Muraro P.A., Golestaneh L., Pascal J., McFarland H.F., and Martin R. Preferential expansion of autoreactive T lymphocytes from the memory T-cell pool by IL-7. J. Neuroimmunol. 100 (1999) 115-123
30. Adamopoulou E., Diekmann J., Tolosa E., Kuntz G., Einsele H., Rammensee H.G., and Topp M.S. Human CD4+ T cells displaying viral epitopes elicit a functional virus-specific memory CD8+ T cell response. J. Immunol. 178 (2007) 5465-5472
31. Burster T., Marin-Esteban V., Boehm B.O., Dunn S., Rotzschke O., Falk K., Weber E., Verhelst S.H., Kalbacher H., and Driessen C. Design of protease-resistant myelin basic protein-derived peptides by cleavage site directed amino acid substitutions. Biochem. Pharmacol. 74 (2007) 1514-1523
32. Delgado M.B., Clark-Lewis I., Loetscher P., Langen H., Thelen M., Baggiolini M., and Wolf M. Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur. J. Immunol. 31 (2001) 699-707
33. Fiebiger E., Meraner P., Weber E., Fang I.F., Stingl G., Ploegh H., and Maurer D. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. 193 (2001) 881-892
34. Burster T., Giffon T., Dahl M.E., Bjorck P., Bogyo M., Weber E., Mahmood K., Lewis D.B., and Mellins E.D. Influenza A virus elevates active cathepsin B in primary murine DC. Int. Immunol. 19 (2007) 645-655
35. Li D.N., Matthews S.P., Antoniou A.N., Mazzeo D., and Watts C. Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo. J. Biol. Chem. 278 (2003) 38980-38990
36. Reich M., van Swieten P.F., Sommandas V., Kraus M., Fischer R., Weber E., Kalbacher H., Overkleeft H.S., and Driessen C. Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins. J. Leukoc. Biol. 81 (2007) 990-1001